Our in vitro effects suggest that EAM-2201 ought to be examined with regard to potential in vivo pharmacokinetic drug–drug interactions attributable to time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 pursuits and aggressive inhibition of UGT1A3 exercise. Identify your collection: Title need to be below 100 characters Select a set: https://friedensreichy727gwm0.mycoolwiki.com/user